Previous News Items
Fall, 2006-- Volume 1, issue 2 of "Chemistry from Berry & Associates" published, featuring new RNA phosphoramidites, QUAL probes, a probe for phytase activity, and much more.
April 5, 2006-- Berry & Associates awarded $749k Phase II SBIR grant for oligonucleotide purification method.
December 1, 2005 -- Berry & Associates has acquired several rare nucleosides, e.g., showdomycin, formycin A, formycin B, pseudouridine, pyrazofurin, toyocamycin, tubercidin, allopurinol riboside, and 5-iodotubercidin. Gram quantities are available but supplies are limited.
February 8, 2005 -- Berry & Associates announces a licensing agreement with Fluorous Technologies, Inc. (FTI), which provides Berry & Associates and its customers access to FTI's proprietary fluorous separation technology.
